What type of study is this?

This is a Cross-Sectional Study study.

Affordability at risk: Inflation, aging, and the future of prescription drug access after IRA reforms.

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional analysis shows rising prescription costs for Medicare cancer patients, indicating ongoing affordability issues post-IRA reforms.

Rising prescription costs threaten access for Medicare cancer patients, with 60% noting increases in the past year.
One-third of patients reported changing medication habits due to affordability issues, including skipping doses or delays.
Despite IRA reforms capping out-of-pocket costs at $2,000, many Medicare patients still face significant financial strain.
Over half of respondents indicated they would reduce or stop medications if costs continued to rise, highlighting a critical access issue.

Gallagher et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Cross-sectional analysis shows rising prescription costs for Medicare cancer patients, indicating ongoing affordability issues post-IRA reforms.